Authors:
Genre, D
Viens, P
Gravis, G
Bertucci, F
Cowen, D
Novakovitch, G
Dermeche, S
Chabannon, C
Oziel-Taieb, S
Camerlo, J
Houvenaeghel, G
Jacquemier, J
Maraninchi, D
Citation: D. Genre et al., Outpatient sequential high dose alkylation with stem cell support for patients with advanced breast cancer: A phase I-II study, ANTICANC R, 20(3B), 2000, pp. 2033-2040
Authors:
Viret, F
Blaise, D
Bouabdallah, R
Stoppa, AM
Novakovitch, G
Faucher, C
Vey, N
Camerlo, J
Oziel-Taieb, S
Ladaique, P
Gastaut, JA
Maraninchi, D
Chabannon, C
Citation: F. Viret et al., Positive selection of CD34+ peripheral blood progenitor cells in patients with low-grade lymphoid malignancies and bone marrow involvement, HEM CELL TH, 41(1), 1999, pp. 5-11
Authors:
Chabannon, C
Blache, JL
Sielleur, I
Douville, J
Faucher, C
Gravis, G
Arnoulet, C
Oziel-Taieb, S
Blaise, D
Novakovitch, G
Camerlo, J
Chabbert, I
Genre, D
Appel, M
Armstrong, D
Maraninchi, D
Viens, P
Citation: C. Chabannon et al., Production of ex vivo expanded hematopoietic cells and progenitors in a closed bioreactor, starting with a small volume marrow collection: A feasibility study in patients with poor-risk breast cancer and receiving high-dosesof cyclophosphamide, INT J ONCOL, 15(3), 1999, pp. 511-518
Authors:
Gravis, G
Pech-Gourgh, F
Viens, P
Alzieu, C
Camerlo, J
Oziel-Taieb, S
Jausseran, M
Maraninchi, D
Citation: G. Gravis et al., Phase II study of a combination of low-dose cisplatin with 13-cis-retinoicacid and interferon-alpha in patients with advanced head and neck squamouscell carcinoma, ANTI-CANC D, 10(4), 1999, pp. 369-374
Authors:
Viens, P
Jacquemier, J
Bardou, VJ
Bertucci, F
Penault-Llorca, F
Puig, B
Gravis, G
Oziel-Taieb, S
Resbeut, M
Houvenaeghel, G
Camerlo, J
Birbaum, D
Hassoun, J
Maraninchi, D
Citation: P. Viens et al., Association of angiogenesis and poor prognosis in node-positive patients receiving anthracycline-based adjuvant chemotherapy, BREAST CANC, 54(3), 1999, pp. 205-212